HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Anil Shanker Selected Research

T-Cell Antigen Receptors (T-Cell Receptor)

12/2015Bortezomib Improves Adoptive T-cell Therapy by Sensitizing Cancer Cells to FasL Cytotoxicity.
1/2010Cooperative action of CD8 T lymphocytes and natural killer cells controls tumour growth under conditions of restricted T-cell receptor diversity.
8/2009Antigen presented by tumors in vivo determines the nature of CD8+ T-cell cytotoxicity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Anil Shanker Research Topics

Disease

35Neoplasms (Cancer)
02/2024 - 01/2003
6Neoplasm Metastasis (Metastasis)
11/2023 - 08/2006
4Lung Neoplasms (Lung Cancer)
02/2024 - 01/2015
4Renal Cell Carcinoma (Grawitz Tumor)
01/2021 - 08/2009
3Melanoma (Melanoma, Malignant)
11/2023 - 12/2015
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2023 - 11/2020
2Body Weight (Weight, Body)
01/2021 - 01/2017
2Inflammation (Inflammations)
08/2015 - 04/2014
1Hearing Loss (Hearing Impairment)
06/2023
1Colitis
01/2021
1Ulcer
01/2021
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2021
1Experimental Melanoma
01/2021
1Esophageal Perforation
11/2020
1Disease Progression
11/2020
1Autoimmune Diseases (Autoimmune Disease)
01/2020
1Neurodegenerative Diseases (Neurodegenerative Disease)
01/2020
1Fibrosarcoma
01/2017
1Adenocarcinoma
01/2017
1Premature Aging
01/2017
1Memory Disorders (Memory Loss)
01/2017
1Bacterial Infections (Bacterial Infection)
04/2016
1Leukemia
01/2016
1Hematologic Neoplasms (Hematological Malignancy)
01/2016
1Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
03/2012
1Multiple Myeloma
03/2012
1Human Influenza (Influenza)
08/2009
1Carcinoma (Carcinomatosis)
05/2008

Drug/Important Bio-Agent (IBA)

12Bortezomib (Velcade)FDA Link
02/2024 - 01/2007
12LigandsIBA
01/2021 - 01/2003
8Proteasome InhibitorsIBA
01/2021 - 01/2007
6AntigensIBA
11/2020 - 08/2009
4CytokinesIBA
01/2019 - 01/2016
4Notch ReceptorsIBA
01/2019 - 10/2015
4PerforinIBA
10/2015 - 08/2006
3Proteins (Proteins, Gene)FDA Link
01/2021 - 04/2014
3CalciumIBA
01/2017 - 04/2014
3T-Cell Antigen Receptors (T-Cell Receptor)IBA
12/2015 - 08/2009
3Proteasome Endopeptidase Complex (Proteasome)IBA
01/2015 - 01/2008
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
05/2010 - 01/2007
2physachenolide CIBA
02/2024 - 01/2021
2Interleukin-15 (Interleukin 15)IBA
01/2017 - 01/2016
2Granzymes (Granzyme)IBA
01/2017 - 10/2015
2Interleukin-2 (IL2)IBA
01/2017 - 01/2016
2Transcription Factors (Transcription Factor)IBA
01/2017 - 10/2015
2Mitochondrial Proteins (Mitochondrial Protein)IBA
01/2017 - 08/2015
2TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA
05/2008 - 02/2006
1Apoptosis Regulatory ProteinsIBA
02/2024
1InterferonsIBA
11/2023
1Adenosine DeaminaseIBA
11/2023
1Adenosine (Adenocard)FDA LinkGeneric
11/2023
1ErbB Receptors (EGF Receptor)IBA
11/2023
1Phosphates (Orthophosphate)IBA
11/2023
1Programmed Cell Death 1 ReceptorIBA
11/2023
1Sirolimus (Rapamycin)FDA Link
06/2023
1Deoxyglucose (2 Deoxy D glucose)IBA
06/2023
1Mucin-6IBA
01/2021
1alpha-DefensinsIBA
01/2021
1Enterotoxins (Enterotoxin)IBA
01/2021
1Poly I-CIBA
01/2021
1PolynucleotidesIBA
01/2021
1MicroRNAs (MicroRNA)IBA
01/2021
1Toll-Like Receptor 4IBA
12/2020
1ethyl 6- (N- (2- chloro- 4- fluorophenyl)sulfamoyl)cyclohex- 1- ene- 1- carboxylateIBA
12/2020
1matrigelIBA
12/2020
1alpha-2-HS-GlycoproteinIBA
12/2020
1L-BLP25IBA
11/2020
1Bevacizumab (Avastin)FDA Link
11/2020
1VaccinesIBA
11/2020
1Neurotransmitter Agents (Neurotransmitter)IBA
01/2020
1Hemagglutinins (Hemagglutinin)IBA
01/2017
1Interleukin-12 (IL 12)IBA
01/2017
1Blocking AntibodiesIBA
01/2017
1Benzo(a)pyreneIBA
04/2016
1Caspase 3 (Caspase-3)IBA
01/2016
1interleukin-21 (interleukin 21)IBA
01/2016
1Histone Deacetylase InhibitorsIBA
01/2016
1Butyrates (Butyrate)IBA
01/2016
1Interleukin-4 (Interleukin 4)IBA
01/2016
1Interleukin-7 (Interleukin 7)IBA
01/2016
1Interleukin-9 (Interleukin 9)IBA
01/2016
1Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
01/2016
1Interleukin-2 Receptors (IL 2 Receptor)IBA
12/2015
1Oncogene Proteins (Oncogene Protein)IBA
11/2015
1Erlotinib Hydrochloride (CP 358,774)FDA Link
11/2015
1AntioxidantsIBA
04/2014
1Immunologic Factors (Immunomodulators)IBA
04/2014
1Caspase 8 (Caspase-8)IBA
05/2010
1Fas Ligand Protein (Fas Ligand)IBA
08/2009
1Peptides (Polypeptides)IBA
08/2009
1Viral HemagglutininsIBA
08/2009
1Monoclonal AntibodiesIBA
05/2008
1EpitopesIBA
11/2007
1Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
08/2006

Therapy/Procedure

13Therapeutics
11/2023 - 08/2009
11Immunotherapy
01/2021 - 01/2007
1Intravenous Administration
01/2021
1Chemoradiotherapy
11/2020
1Intravenous Injections
01/2017
1Drug Therapy (Chemotherapy)
01/2015